Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML
June 03, 2026
June 03, 2026
BUFFALO, New York, June 3 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML
*
BUFFALO, N.Y. -New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational treatment approach using the targeted therapy ziftomenib for patients with a . . .
* * *
Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML
*
BUFFALO, N.Y. -New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational treatment approach using the targeted therapy ziftomenib for patients with a . . .